Comparison of long-term safety and efficacy of omalizumab in chronic urticaria: 9 year retrospective study

J. Marcelino, A. C. Costa, P. Silva, A. Mendes, E. Alonso, F. Duarte, P. Aguiar, E. Pedro, M. Pereira Barbosa

Research output: Contribution to journalMeeting Abstract

Original languageEnglish
Pages (from-to)558-558
JournalAllergy - European Journal of Allergy and Clinical Immunology
Volume71
Issue numberSuppl102
Publication statusPublished - Aug 2016
EventEuropean Academy of Allergy and Clinical Immunology Congress - Vienna, Austria
Duration: 11 Jun 201615 Jun 2016

Cite this

Marcelino, J., Costa, A. C., Silva, P., Mendes, A., Alonso, E., Duarte, F., ... Pereira Barbosa, M. (2016). Comparison of long-term safety and efficacy of omalizumab in chronic urticaria: 9 year retrospective study. Allergy - European Journal of Allergy and Clinical Immunology, 71(Suppl102), 558-558.